Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

Lambert-Niclot, Sidonie;Grude, Maxime;Meynard, Jean-Luc;Marcelin, Anne-Geneviève;Valantin, Marc-Antoine;Flandre, Philippe;Izopet, Jacques;Moinot, Laetitia;Bouteloup, Vincent;Calvez, Vincent;Katlama, Christine;Girard, Pierre-Marie;Morand-Joubert, Laurence;
clinical infectious diseases 2018 Vol. 67 pp. 1883-1889
140
sidonie2018clinicalultrasensitive

Abstract

Protease inhibitor (PI) monotherapy is a potential approach to alleviate antiretroviral treatment. We pooled the results of 3 PI/r monotherapy trials and demons

Keywords

Access

URL:
https://doi.org/10.1093/cid/ciy382

Citation

ID: 268121
Ref Key: sidonie2018clinicalultrasensitive
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
268121
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store